Press Releases Sonoma Pharmaceuticals, Inc.

Equities

SNOA

US83558L2043

Market Closed - Nasdaq Other stock markets 04:30:00 2024-06-07 pm EDT			5-day change	1st Jan Change
0.205 ^USD	+9.45%		+0.15%	+13.64%

May. 09	Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores	CI
Feb. 08	Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States	Apr. 10	AQ
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections	Apr. 05	AQ
Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals	Mar. 28	AQ
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results	Feb. 09	AQ
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union through Sonoma's Extensive Distributor Network	Jan. 10	AQ
Sonoma Pharmaceuticals : Material Agreement - Form 8-K	Dec. 18	PU
Sonoma Pharmaceuticals : Investor Presentation October 2023 - Form 8-K	23-10-11	PU
National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced	23-08-16	AQ
Sonoma Pharmaceuticals : Regulation FD Presentation - Form 8-K	23-05-10	PU
SONOMA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-05-10	AQ
SONOMA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-04-13	AQ
Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care	23-04-12	AQ
Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia	23-03-29	AQ
Sonoma Pharmaceuticals : Material Agreement - Form 8-K	23-02-24	PU
SONOMA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-02-24	AQ
Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results	23-02-15	AQ
SONOMA PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-02-14	AQ
SONOMA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-01-31	AQ
SONOMA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-01-06	AQ
SONOMA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-12-30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sonoma Pharmaceuticals, Inc.

Equities

SNOA

US83558L2043

Press Releases

Filters